ALSP: Clinical Trials

5 trials for ALSP, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed, 1 enrolling by invitation, 1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow ALSP: new trials by email Literature Review of ALSP trials Research Report on ALSP

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia
VGL101 - ALSP
Phase 2TerminatedVigil Neuroscience, Inc.202022-12-142025-06-11
Natural History Study in Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia
No intervention - ALSP
TerminatedVigil Neuroscience, Inc.562021-09-132025-08-13
A Study to Assess CSF1R-related Leukoencephalopathy After Stem Cell Transplantation
CSF1R-related Leukoencephalopathy, ALSP
Enrolling by invitationMayo Clinic202020-07-212026-01-08
LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
Leukodystrophy, White Matter Disease
CompletedChildren's Hospital of Philadelphia2362017-01-062025-11-10
The Myelin Disorders Biorepository Project
Leukodystrophy, White Matter Disease
RecruitingChildren's Hospital of Philadelphia120002016-12-082025-10-23

Narrower conditions

Leukoencephalopathies (5)  ·  Hereditary Diffuse Leukoencephalopathy with Spheroids (3)  ·  Adrenoleukodystrophy (2)  ·  Aicardi-Goutieres syndrome (2)  ·  Alexander Disease (2)  ·  Alexanders leukodystrophy (2)  ·  Allan-Herndon-Dudley syndrome (2)  ·  Attention Deficit Disorder with Hyperactivity (2)  ·  CADASIL (2)  ·  Canavan Disease (2)  ·  Charcot-Marie-Tooth Disease (2)  ·  Cockayne Syndrome (2)  ·  Gangliosidoses (2)  ·  Gangliosidoses, GM2 (2)  ·  Leukodystrophy, Globoid Cell (2)

Broader conditions

Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Nervous System Diseases (5)  ·  Abnormalities, Multiple (2)  ·  Adrenal Gland Diseases (2)  ·  Adrenal Insufficiency (2)  ·  Arthritis (2)  ·  Arthritis, Rheumatoid (2)  ·  Attention Deficit and Disruptive Behavior Disorders (2)  ·  Autoimmune Diseases (2)  ·  Bone Diseases (2)  ·  Bone Diseases, Developmental (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Brain Infarction (2)

Sponsors

Children's Hospital of Philadelphia (2)  ·  Vigil Neuroscience, Inc. (2)  ·  Mayo Clinic (1)

Countries

United States (5)  ·  Germany (2)  ·  Netherlands (2)  ·  United Kingdom (2)  ·  Brazil (1)  ·  Canada (1)  ·  France (1)

Top investigators

Adeline Vanderver, MD (2)  ·  Zbigniew K Wszolek, MD (1)

Results publications

PMID 32342562, PMID 32749716

NIH funding

U01NS106845 (1), U54NS115052 (1)